Case-Based Review

Management of Locally Advanced Rectal Adenocarcinoma


 

Colorectal cancers are among the most common cancers worldwide, and there is a high mortality rate for advanced-stage disease. Approximately 132,000 new cases of colorectal cancer will be diagnosed in the United States in 2015, and approximately 40,000 of these cases will be primary rectal cancers. The incidence and mortality rates have been steadily declining over the past two decades, largely through advances in screening and improvements in treatment. However, rectal cancer remains a significant cause of morbidity and mortality in the United States and worldwide.

To read the full article in PDF:

Click here

Recommended Reading

Adding enhanced MR to CT might improve diagnosis, outcomes in hepatocellular carcinoma
MDedge Hematology and Oncology
Aspirin, vitamin D levels protect against recurrent CRC
MDedge Hematology and Oncology
DDW: Study finds pancreatic cancer misdiagnosis rate at 31%
MDedge Hematology and Oncology
Hereditary cancer syndromes highly prevalent in young adults with colorectal cancer
MDedge Hematology and Oncology
Targeting H. pylori may help prevent stomach cancer
MDedge Hematology and Oncology
Circulating tumor DNA marked progressive liver cancer
MDedge Hematology and Oncology
New guidelines stress identifying Lynch syndrome
MDedge Hematology and Oncology
Biomarkers are being harnessed to improve colorectal cancer detection
MDedge Hematology and Oncology
Aspirin, weight loss cut colorectal cancer risk in Lynch syndrome
MDedge Hematology and Oncology
Regorafenib provides low value in metastatic colorectal cancer
MDedge Hematology and Oncology